Compare Trulieve Cannabis Corp. with Similar Stocks
Stock DNA
Other Agricultural Products
CAD 2,027 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.04
-10.76%
1.21
Revenue and Profits:
Net Sales:
418 Million
(Quarterly Results - Jun 2025)
Net Profit:
-22 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
65.48%
0%
65.48%
6 Months
33.24%
0%
33.24%
1 Year
-25.68%
0%
-25.68%
2 Years
82.8%
0%
82.8%
3 Years
-45.27%
0%
-45.27%
4 Years
-78.79%
0%
-78.79%
5 Years
-44.43%
0%
-44.43%
Trulieve Cannabis Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
23.31%
EBIT Growth (5y)
33.28%
EBIT to Interest (avg)
3.83
Debt to EBITDA (avg)
1.07
Net Debt to Equity (avg)
0.14
Sales to Capital Employed (avg)
0.64
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
16.66%
ROE (avg)
3.00%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.24
EV to EBIT
19.45
EV to EBITDA
6.17
EV to Capital Employed
1.23
EV to Sales
1.34
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.30%
ROE (Latest)
-14.34%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 11 Foreign Institutions (0.03%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
418.10
427.20
-2.13%
Operating Profit (PBDIT) excl Other Income
130.50
112.40
16.10%
Interest
22.70
23.40
-2.99%
Exceptional Items
0.30
-2.60
111.54%
Consolidate Net Profit
-21.90
-46.10
52.49%
Operating Profit Margin (Excl OI)
169.40%
117.90%
5.15%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -2.13% vs 1.45% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 52.49% vs 45.51% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,625.40
1,524.10
6.65%
Operating Profit (PBDIT) excl Other Income
360.50
350.20
2.94%
Interest
85.20
110.10
-22.62%
Exceptional Items
7.20
-410.80
101.75%
Consolidate Net Profit
-212.20
-588.30
63.93%
Operating Profit Margin (Excl OI)
71.90%
82.00%
-1.01%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 6.65% vs -3.90% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 63.93% vs -147.50% in Dec 2023
About Trulieve Cannabis Corp. 
Trulieve Cannabis Corp.
Other Agricultural Products
Trulieve Cannabis Corp is a Canada-based seed to sale licensed medical cannabis company. The Company cultivates and produces all of its products in-house and distributes those products to Trulieve branded stores (dispensaries), as well as directly to patients through home delivery. It also operates in California, Massachusetts and Connecticut. The Company offers a range of products, such as concentrates, flower, oil, capsules and tinctures. It operates a 35,000 square foot cultivation and processing facility in McKeesport, Pennsylvania. It operates three dispensaries, located in Pittsburgh-area locations and also offers medical marijuana relief solutions for Pennsylvanians certified with serious medical conditions. The Company's subsidiaries include PurePenn LLC, Pioneer Leasing & Consulting LLC and Keystone Relief Centers LLC.






